Catalyst Wire Dossier Catalyst Wire Dossier

Sleeping Beauty TCR autologous T-cell therapy

· Alaunos Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sleeping Beauty TCR autologous T-cell therapy, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

See pricing